Vaccines | Free Full-Text | Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
RNA selectable marker DNA vaccine plasmids. Purple arrow in bacterial... | Download Scientific Diagram
Vaccines | Free Full-Text | Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
Adenovirus (Ad) as Vaccine-vectors - Creative Biolabs
Landscape and selection of vaccine epitopes in SARS-CoV-2 | Genome Medicine | Full Text
Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG | PLOS ONE
Insertion of a selectable marker by recombineering.(a) Targeting... | Download Scientific Diagram
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 12
The New Humanitarian | Coronavirus maps and humanitarian data: Tracking COVID-19 and vaccine rollouts
Vaccine vial monitor (VVM)
A NOVEL CRE RECOMBINASE-MEDIATED IN VIVO MINICIRCLE DNA (CRIM) VACCINE PROVIDES PARTIAL PROTECTION AGAINST NEWCASTLE DISEASE VIR
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 13
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study -
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
A Selectable and Excisable Marker System for the Rapid Creation of Recombinant Poxviruses | PLOS ONE
Ensuring safety of DNA vaccines | Microbial Cell Factories | Full Text
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR
